A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
about
Eicosanoids in the innate immune response: TLR and non-TLR routesCell proliferation depends on mitochondrial Ca2+ uptake: inhibition by salicylateTriflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillationInterleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization.Effect of Triflusal on Primary Vascular Dysregulation Compared with Aspirin: A Double-Blind, Randomized, Crossover Trial.Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial.NFAT as cancer target: mission possible?Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD).Inflammation as a Therapeutic Target for Diabetic Neuropathies.Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?Armillariella mellea shows anti-inflammatory activity by inhibiting the expression of NO, iNOS, COX-2 and cytokines in THP-1 cells.Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cells.Comparative effects of triflusal, S-adenosylmethionine, and dextromethorphan over intestinal ischemia/reperfusion injury
P2860
Q27690699-CD693D7F-D99D-49BE-8592-4799AA2EE12DQ28193861-E476B467-D916-48B1-AF25-364DC4ABD999Q28196625-9462F708-BF47-4370-8268-B7AA3B9205B5Q30428747-AA520FD1-FC23-4F98-92CD-BD2FB6B6D286Q30661716-0FEC62F0-606E-4788-8146-F073A5233ADBQ34027442-096C177F-D743-444F-AD9F-87BDFD87D145Q36455193-DBE97CD6-8581-4F2C-BFEE-5E97A341068CQ37331296-0AF78016-562D-4FB8-8494-763BF956AF91Q37450547-DE7D635A-BF90-44E6-BB66-E6BDC5F25CBEQ37622487-165643D0-8A08-4D3B-9E40-EB37DD48FF11Q40114210-0B63D116-1214-4DCB-84AE-A50135AE5049Q40218846-A56F332E-4609-4438-809E-425516250BBEQ58694385-BD483A83-4EA5-407F-9212-D4FA0A14F58F
P2860
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@ast
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@en
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@nl
type
label
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@ast
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@en
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@nl
prefLabel
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@ast
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@en
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@nl
P2093
P1476
A new pharmacological effect of salicylates: inhibition of NFAT-dependent transcription
@en
P2093
Ana Dueñas
Carmen García-Rodríguez
Cristina Gómez
Edurne San Vicente
Mariano Sánchez Crespo
Mónica Aceves
P304
P356
10.4049/JIMMUNOL.173.9.5721
P407
P577
2004-11-01T00:00:00Z